All Phenotypes Ncstn<tm1.1Akli> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Ncstn^tm1.1Akli
targeted mutation 1.1, Apostolos Klinakis
MGI:5009035

Summary

6 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0	involves: 129	MGI:5496430
cn2	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Upk2-cre,-EGFP)#Akli/0	involves: 129	MGI:5779426
cn3	Gt(ROSA)26Sor^{tm1.1(rtTA2S*M2)Whsu}/Gt(ROSA)26Sor⁺ Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(tetO-cre)1Jaw/0	involves: 129 * 129S6/SvEvTac * C57BL/6	MGI:5779422
cn4	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Mx1-cre)1Cgn/0	involves: 129 * C57BL/6 * CBA * SJL	MGI:5009036
cn5	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0	involves: 129 * C57BL/6 * SJL	MGI:5009037
cn6	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0	involves: 129S/SvEv * C57BL/6	MGI:5496428

Allelic Composition	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0
Genetic Background	involves: 129

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tg(VAV1-cre)1Graf mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:196407 )

immune system

enlarged spleen ( J:196407 )

abnormal splenocyte physiology ( J:196407 )

• splenocytes transplanted into lethally irradiated recipients induce increased myeloid cell counts in peripheral blood compared with cells from control mice

• however, transplanted cells do not induce lethal myeloid leukemia

hematopoietic system

enlarged spleen ( J:196407 )

abnormal splenocyte physiology ( J:196407 )

• splenocytes transplanted into lethally irradiated recipients induce increased myeloid cell counts in peripheral blood compared with cells from control mice

• however, transplanted cells do not induce lethal myeloid leukemia

growth/size/body

enlarged spleen ( J:196407 )

Allelic Composition	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Upk2-cre,-EGFP)#Akli/0
Genetic Background	involves: 129

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tg(Upk2-cre,-EGFP)#Akli mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased urinary bladder carcinoma incidence ( J:227748 )

• within 2-6 months of age, mice develop bladder tumors that consist of simple and nodular hyperplasia, as well as high-grade dysplasia and carcinoma in situ showing basal characteristics

renal/urinary system

increased urinary bladder carcinoma incidence ( J:227748 )

• within 2-6 months of age, mice develop bladder tumors that consist of simple and nodular hyperplasia, as well as high-grade dysplasia and carcinoma in situ showing basal characteristics

hydronephrosis ( J:227748 )

• mice develop occasional unilateral hydronephrosis within 2-6 months due to ureter obstruction

ureter obstruction ( J:227748 )

• due to bladder tumors

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
urinary bladder cancer		DOID:11054	OMIM:109800	J:227748

Allelic Composition	Gt(ROSA)26Sor^{tm1.1(rtTA2S*M2)Whsu}/Gt(ROSA)26Sor⁺ Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(tetO-cre)1Jaw/0
Genetic Background	involves: 129 * 129S6/SvEvTac * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm1.1(rtTA2S*M2)Whsu} mutation (0 available); any Gt(ROSA)26Sor mutation (942 available)
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tg(tetO-cre)1Jaw mutation (5 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased urinary bladder carcinoma incidence ( J:227748 )

• doxycycline (dox) treated mice rapidly develop invasive urothelial cancer

• tumors of dox treated mice are high-grade urothelial carcinomas, grow mostly with a solid, non-glandular pattern and show blunt cellular atypia and focal glandular differentiation

• tumors invade the lamina and muscularis propria

• marker analysis indicates that tumors are related to human basal BLCA3 subtype

renal/urinary system

increased urinary bladder carcinoma incidence ( J:227748 )

• doxycycline (dox) treated mice rapidly develop invasive urothelial cancer

• tumors of dox treated mice are high-grade urothelial carcinomas, grow mostly with a solid, non-glandular pattern and show blunt cellular atypia and focal glandular differentiation

• tumors invade the lamina and muscularis propria

• marker analysis indicates that tumors are related to human basal BLCA3 subtype

hydronephrosis ( J:227748 )

• 12 of 18 mice develop unilateral or bilateral hydronephrosis as early as 2 weeks after dox treatment due to obstruction of the upper ureter by tumor masses

ureter obstruction ( J:227748 )

• due to bladder tumors in dox treated mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
urinary bladder cancer		DOID:11054	OMIM:109800	J:227748

Allelic Composition	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Mx1-cre)1Cgn/0
Genetic Background	involves: 129 * C57BL/6 * CBA * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tg(Mx1-cre)1Cgn mutation (7 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:172442 )

• do not survive more than 20 weeks after induction of cre mediated recombination

hematopoietic system

abnormal definitive hematopoiesis ( J:172442 )

• significant reduction of the lymphoid-biased multipotential progenitor population (L-MPP) after induction of cre mediated recombination

• striking increase in the absolute numbers of both bone marrow and spleen granulocyte/monocyte progenitors cells after induction of cre mediated recombination

• decrease of the megakaryocyte?erythrocyte progenitor population after induction of cre mediated recombination

• progenitor cells display an increase in their self-renewal capacity after induction of cre mediated recombination

increased leukocyte cell number ( J:172442 )

• striking peripheral blood leukocytosis after induction of cre mediated recombination

increased monocyte cell number ( J:172442 )

• striking peripheral blood monocytosis after induction of cre mediated recombination

• increase in monocyte numbers in the bone marrow and liver after induction of cre mediated recombination

abnormal hematopoietic stem cell morphology ( J:172442 )

• de-repression of an extended myeloid-specific program in LSK cells

increased hematopoietic stem cell number ( J:172442 )

• increase in LSK numbers after induction of cre mediated recombination

abnormal spleen morphology ( J:172442 )

• expansion of the red pulp with diffuse infiltration by myeloid and monocytic cells after induction of cre mediated recombination

enlarged spleen ( J:172442 )

• after induction of cre mediated recombination

increased spleen red pulp amount ( J:172442 )

• expansion of the red pulp after induction of cre mediated recombination

neoplasm

increased leukemia incidence ( J:172442 )

• similarity to chronic myelomonocytic leukemia after induction of cre mediated recombination

immune system

increased leukocyte cell number ( J:172442 )

• striking peripheral blood leukocytosis after induction of cre mediated recombination

increased monocyte cell number ( J:172442 )

• striking peripheral blood monocytosis after induction of cre mediated recombination

• increase in monocyte numbers in the bone marrow and liver after induction of cre mediated recombination

abnormal spleen morphology ( J:172442 )

• expansion of the red pulp with diffuse infiltration by myeloid and monocytic cells after induction of cre mediated recombination

enlarged spleen ( J:172442 )

• after induction of cre mediated recombination

increased spleen red pulp amount ( J:172442 )

• expansion of the red pulp after induction of cre mediated recombination

growth/size/body

enlarged spleen ( J:172442 )

• after induction of cre mediated recombination

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
chronic myeloid leukemia		DOID:8552	OMIM:608232	J:172442

Allelic Composition	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0
Genetic Background	involves: 129 * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tg(VAV1-cre)1Graf mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:172442 )

• do not survive more than 20 weeks

hematopoietic system

abnormal definitive hematopoiesis ( J:172442 )

• significant reduction of the lymphoid-biased multipotential progenitor population (L-MPP)

• striking increase in the absolute numbers of both bone marrow and spleen granulocyte/monocyte progenitors cells

• decrease of the megakaryocyte?erythrocyte progenitor population

• progenitor cells display an increase in their self-renewal capacity

increased leukocyte cell number ( J:172442 )

• striking peripheral blood leukocytosis

increased monocyte cell number ( J:172442 )

• striking peripheral blood monocytosis

• increase in monocyte numbers in the bone marrow and liver

abnormal hematopoietic stem cell morphology ( J:172442 )

• de-repression of an extended myeloid-specific program in LSK cells

increased hematopoietic stem cell number ( J:172442 )

• increase in LSK numbers

abnormal spleen morphology ( J:172442 )

• expansion of the red pulp with diffuse infiltration by myeloid and monocytic cells

enlarged spleen ( J:172442 )

increased spleen red pulp amount ( J:172442 )

• expansion of the red pulp

neoplasm

increased leukemia incidence ( J:172442 )

• similarity to chronic myelomonocytic leukemia

immune system

increased leukocyte cell number ( J:172442 )

• striking peripheral blood leukocytosis

increased monocyte cell number ( J:172442 )

• striking peripheral blood monocytosis

• increase in monocyte numbers in the bone marrow and liver

abnormal spleen morphology ( J:172442 )

• expansion of the red pulp with diffuse infiltration by myeloid and monocytic cells

enlarged spleen ( J:172442 )

increased spleen red pulp amount ( J:172442 )

• expansion of the red pulp

growth/size/body

enlarged spleen ( J:172442 )

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
chronic myeloid leukemia		DOID:8552	OMIM:608232	J:172442

Allelic Composition	Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0
Genetic Background	involves: 129S/SvEv * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ncstn^tm1.1Akli mutation (0 available); any Ncstn mutation (33 available)
Tet2^tm1.1Iaai mutation (2 available); any Tet2 mutation (778 available)
Tg(VAV1-cre)1Graf mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:196407 )

• mice die at 26 weeks

immune system

enlarged spleen ( J:196407 )

• with massive infiltration of differentiated and blast-like myeloid cells

myeloid hyperplasia ( J:196407 )

• increased circulating blast-like cells at 7 weeks after birth

• massive infiltration of differentiated and blast-like myeloid cells in the spleen

increased leukocyte cell number ( J:196407 )

• with an increase in absolute myelomonocytic and blast-like cells 7 weeks after birth

neoplasm

abnormal tumor pathology ( J:196407 )

• spleen tumor cells transplanted into lethally irradiated recipients induce increased myeloid cell counts in peripheral blood and lethality compared with cells from control mice

increased leukemia incidence ( J:196407 )

• massive infiltration of differentiated and blast-like myeloid cells in the spleen

hematopoietic system

enlarged spleen ( J:196407 )

• with massive infiltration of differentiated and blast-like myeloid cells

abnormal common myeloid progenitor cell morphology ( J:196407 )

• enlarged granulocyte-macrophage progenitor (GMP) compartment

myeloid hyperplasia ( J:196407 )

• increased circulating blast-like cells at 7 weeks after birth

• massive infiltration of differentiated and blast-like myeloid cells in the spleen

increased leukocyte cell number ( J:196407 )

• with an increase in absolute myelomonocytic and blast-like cells 7 weeks after birth

growth/size/body

enlarged spleen ( J:196407 )

• with massive infiltration of differentiated and blast-like myeloid cells

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/09/2024 MGI 6.23